Abstract
Secoisolariciresinol diglucoside (SDG) isolated from flaxseed has antioxidant activity and has been shown to prevent hypercholesterolemic atherosclerosis. An investigation was made of the effects of SDG on the development of diabetes in diabetic prone BioBreeding rats (BBdp rats), a model of human type I diabetes [insulin dependent diabetes mellitus (IDDM)] to determine if this type of diabetes is due to oxidative stress and if SDG can prevent the incidence of diabetes. The rats were divided into three groups: Group I, BioBreeding normal rats (BBn rats) (n = 10); group II, BBdp untreated (n = 11); and group III, BBdp treated with SDG 22 mg/kg body wt, orally) (n = 14). Oxidative stress was determined by measuring lipid peroxidation product malondialdehyde (MDA) an index of level of reactive oxygen species in blood and pancreas; and pancreatic chemiluminescence (Pancreatic-CL), a measure of antioxidant reserve. Incidence of diabetes was 72.7% in untreated and 21.4% in SDG-treated group as determined by glycosuria and hyperglycemia. SDG prevented the development of diabetes by approximately 71%. Development of diabetes was associated with an increase in serum and pancreatic MDA and a decrease in antioxidant reserve. Prevention in development of diabetes by SDG was associated with a decrease in serum and pancreatic-MDA and an increase in antioxidant reserve. These results suggest that IDDM is mediated through oxidative stress and that SDG prevents the development of diabetes.
Similar content being viewed by others
References
Nerup J: HLA studies in diabetes mellitus. A Review. Adv Metab Disord 9: 263-273, 1978
Rayfield EJ, Kelly KJ, Yoon JW: Rubella virus-induced diabetes in hamster. Diabetes 35: 1276-1281, 1986
Ginsberg-Fellener F, Witt ME, Yagihashi S, Dobersen MJ, Taub F, Fedun B, McCoy RC, Roman SH, Davies TF, Cooper LZ, Rubenstein P, Notteins AL: Congenital rubella syndrome as a model for Type I (insulin-dependent) diabetes mellitus: Increased prevalance of islet cell surface antibodies. Diabetologia 27: 87-89, 1984
Rabinovitch A, Suarez WL, Thomas PD, Strynadka K, Simpson I: Cytotoxic effects of cytokines on rat islets: Evidence for involvement of free radicals and lipid peroxidation. Diabetologia 35: 409-413, 1992
Dulin WE, Soret MG: Chemically and hormonally induced diabetes. In: M.E. Volk, K.F. Wellman (eds). The Diabetic Pancreas. Plenum Press, New York, 1977, pp 425-465
Junod A, Lambert AE, Orci L, Pictet R, Gonent AE, Renold AE: Studies of the diabetogenic action of streptozotocin. Pro Soc Expt Biol Med 126: 201-205, 1967
Barbosa J, Bach FH: Cell mediated autoimmunity in Type I diabetes. Diabetes Metab Rev 3: 981-1004, 1987
Charlton BA, Bacelj A, Mandel TE: Administration of silica particles or anti Lyt 2 antibody prevents beta-cell destruction in mice given cyclophosphamide. Diabetes 37: 930-935, 1988
Nathan CF, Tsunawaki S: Secretion of toxic oxygen products by macrophages: Regulatory cytokines and their effects on the oxidase. Ciba Foundation Symposium 118: 211-230, 1986
Berton G, Zeni L, Cassatella MA, Rossi F: Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 138: 1276-1282, 1986
Braquet P, Hosfard D, Braquet M, Bourgain R, Bussolino F: Role of cytokines and platelet activating factor in microvascular injury. Int Arch Allerg Appl Immunol 88: 88-100, 1989
Paubert-Braquet M, Longchamps MA, Kolz P: Tumor necrosis factor (TNF) primes human neutrophil (PMN) platelet-activating factor (PAF)-induced superoxide generation. Consequences in promoting PMN-mediated endothelial cell (EC) damages. Prostaglandins 35: (abstr) 803, 1988
Freeman BA, Crapo JD: Biology of disease. Free radicals and tissue injury. Lab Invest 47: 412-426, 1982
Meerson FZ, Kagan VE, Kozlov YP, Belkina LM, Arkhipenko YV: The role of lipid peroxidation in pathogenesis of ischemic damage and antioxidant protection of the heart. Basic Res Cardiol 77: 465-468, 1982
Sumoski W, Baquerizo H, Rabinovitch A: Oxygen radical scavengers protect rat islet cells from damage by cytokines. Diabetologia 32: 792-796, 1989
Prasad K: Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132: 69-76, 1997
Prasad K, Mantha SV, Muir AD, Westcott ND: Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 136: 367-375, 1998
Kelley DS, Branch LB, Love JE, Taylor PC, Rivera YM, Iacono JM: Dietary alpha-linolenic acid and immunocompetence in humans. Am J Clin Nutr 53: 40-46, 1991
Cox CP, Wood KL: Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion of washed rabbit platelets by (CV-3988, L-652731, trizolam and alphazolam. Thromb Res 47: 249-257, 1987
Westcott ND, Muir AD: Process for extracting lignans from flaxseed. U.S. Patent NO. 5705618, Jan 1988
Prasad K: Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Mol Cell Biochem 168: 117-123, 1997
Mordes JP, Desemone J, Rossini AA: The BB rat Diabetes Metab Rev 3: 725-750, 1987
Prasad K, Gupta JB, Kalra J, Lee P, Mantha SV, Bharadwaj B: Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 28: 375-385, 1996
Kapoor R, Prasad K: Role of oxyradicals in cardiovascular depression and cellular injury in hemorrhagic shock and re-infusion: Effect of SOD and catalase. Circ Shock 43: 79-94, 1994
Prasad K, Kalra J: Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 125: 958-973, 1993
Prasad K, Kalra J, Lee P: Oxygen free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of Probucol. Int J Angiol 3: 100-112, 1994
Cornall AG, Bardwill CJ, David MM: Determination of serum proteins by means of biuret reaction. J Biol Chem 177: 751-776, 1949
Kadish AH, Little RL, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116-131, 1968
Laupacis A, Gardell C, Dupre J, Stiller CR, Keown P, Wallace AC, Thibert P: Cytosporin prevents diabetes in BB Wistar rats. Lancet I: 10-12, 1983
Lefkowith J, Schreiner G, Cormier J, Handler ES, Driscoll HK, Greiner D, Mordes JP, Rossini AA: Prevention of diabetes in the BB rat by essential fatty acid deficiency: Relationship between physiological and biochemical changes. J Exp Med 171: 729-743, 1990
Prasad K: Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside (SDG) isolated from flaxseed. Circulation 99: 1355-1362, 1999
Jain SK, Levine SN, Duett J, Hollier B: Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism 39: 971-975, 1990
Kakkar R, Kalra J, Mantha SV, Prasad K: Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151: 113-119, 1995
Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J: Increased oxidative stess in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci 94: 623-632, 1998
Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnet AH: Increased diene conjugates in diabetic subjects with micoroangiopathy. Diabetic Med 4: 452-456, 1987
Godin DV, Wohaeib SA, Garnett ME, Goumeniouk AD: Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84: 223-231, 1988
Hunt JV, Smith CCT, Wolff SP: Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39: 420-424, 1990
Wolff SP, Dean RT: Glucose autoxidation and protein modification, the potential role of autoxidative glycosylation in diabetes. Biochem J 245: 243-250, 1987
Cadenas E, Sies H: Low level chemiluminescence of liver microsomal fractions initiated by tert-butyl hydroperoxide: relation to microsomal hemoproteins, oxygen dependence, and lipid peroxidation. Eur J Biochem 124: 349-356, 1982
Cadenas E, Varsavsky AI, Boveris A, Chance B: Oxygen or organic hydroperoxide-induced chemiluminescence of brain and liver homogenates. Biochem J 198: 645-654, 1981
Cadenas E, Wefers H, Sies H: Low level chemiluminescence of isolated hepatocytes. Eur J Biochem 119: 531-536, 1981
Grankvist K, Marklund S, Sehlin J, Teljedal IB: Superoxide dismutase, catalase and scavengers of hydorxyl radicals protect against the toxic action of alloxan on pancreatic islet cells in vitro. Biochem J 182: 17-25, 1979
Mclennan SV, Heffernen S, Wright l, Rae C, Fisher E, Yue OK, Turtle JR: Changes in hepatic glutathione metabolites in diabetes. Diabetes 40: 344-348, 1991
Murakami R, Knodo T, Ohtsuka Y, Fijiwara Y, Shimada M, Kaloakame Y: Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus. Metabolism 38: 753-758, 1989
Asplund K, Grankvist K, Marklund S, Taljedal LB: Partial protection against streptozotocin induced hyperglycemia by superoxide dismutase linked to polyethlyene glycol. Acta Endocrinol 107: 390-394, 1984
Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER: The effects of desferrioxamine and ascorbate on oxidative stress in streptozotosin diabetic rat. Free Radic Biol Med 18: 833-840, 1995
Gorsch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG: Evidence for a long prediabetic period in Type I (insulin dependent) diabetes mellitus. Lancet ii: 1363-1366, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prasad, K. Oxidative stress as a mechanism of diabetes in diabetic BB prone rats: Effect of secoisolariciresinol diglucoside (SDG). Mol Cell Biochem 209, 89–96 (2000). https://doi.org/10.1023/A:1007079802459
Issue Date:
DOI: https://doi.org/10.1023/A:1007079802459